VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (0)
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
YOUNG, KEN HE
One or more keywords matched the following items that are connected to
YOUNG, KEN HE
Item Type
Name
Academic Article
Signaling pathway and dysregulation of PD1 and its ligands in lymphoid malignancies.
Academic Article
Immune checkpoint blockade: Releasing the brake towards hematological malignancies.
Academic Article
Checkpoint inhibitors in hematological malignancies.
Academic Article
Targeting the programmed death-1 pathway in lymphoid neoplasms.
Academic Article
PD-1 expression and clinical PD-1 blockade in B-cell lymphomas.
Academic Article
Clinical Significance of PTEN Deletion, Mutation, and Loss of PTEN Expression in De Novo Diffuse Large B-Cell Lymphoma.
Academic Article
B-cell receptor-mediated NFATc1 activation induces IL-10/STAT3/PD-L1 signaling in diffuse large B-cell lymphoma.
Academic Article
PD-1/PD-L1 expression and interaction by automated quantitative immunofluorescent analysis show adverse prognostic impact in patients with diffuse large B-cell lymphoma having T-cell infiltration: a study from the International DLBCL Consortium Program.
Academic Article
Immune Profiling and Quantitative Analysis Decipher the Clinical Role of Immune-Checkpoint Expression in the Tumor Immune Microenvironment of DLBCL.
Concept
B7-H1 Antigen
Academic Article
Immunoglobulin somatic hypermutation has clinical impact in DLBCL and potential implications for immune checkpoint blockade and neoantigen-based immunotherapies.
Academic Article
PD-L1 translocation to the plasma membrane enables tumor immune evasion through MIB2 ubiquitination.
Academic Article
CD19-specific CAR T Cells that Express a PD-1/CD28 Chimeric Switch-Receptor are Effective in Patients with PD-L1-positive B-Cell Lymphoma.
Academic Article
miR-21 depletion in macrophages promotes tumoricidal polarization and enhances PD-1 immunotherapy.
Academic Article
Activity of pembrolizumab in relapsed/refractory NK/T-cell lymphoma.
Search Criteria
B7 2 Antigen